Molecular analysis based on mtLSU-rRNA and DHPS sequences of Pneumocystis jirovecii from immunocompromised and immunocompetent patients in Italy

Infection, Genetics and Evolution

Volumn 14, Issue 1, 2013, Pages 68-72

  Dimonte, S ^a   Berrilli, F ^a   D'Orazi, C ^b   D'Alfonso, R ^a   Placco, F ^a   Bordi, E ^c   Perno, C F ^a,b,c   Di Cave, D ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^c NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

Author keywords

DHPS; Genotypes; MtLSU rRNA; Pneumocystis jirovecii; Prevalence

Indexed keywords

RIBOSOME RNA;

ADULT; ARTICLE; CANDIDA; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HAEMOPHILUS PARAINFLUENZAE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPETENCE; IMMUNOCOMPROMISED PATIENT; ITALY; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MOLECULAR DIAGNOSIS; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SEQUENCE ALIGNMENT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CHILD; CODON; DIHYDROPTEROATE SYNTHASE; FEMALE; GENOTYPE; HUMANS; IMMUNOCOMPROMISED HOST; ITALY; MALE; MIDDLE AGED; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RIBOSOME SUBUNITS, LARGE; RNA; YOUNG ADULT;

FUNGI; PNEUMOCYSTIS JIROVECII;

EID: 84871873236     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2012.11.012     Document Type: Article

References (55)

1. Agostoni F., Atzori C., Angeli E., Mainini A., Micheli V., Cargnel A. Pneumocystis carinii diagnosis: an update. Int. J. Antimicrob. Agents 2000, 16:549-557.
2. Armstrong W., Meshnick S., Kazanjian P. Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in immunocompromised patients. Microbes Infect. 2000, 2:61-67.
3. Beard C.B., Carter J.L., Keely S.P., Huang L., Pieniazek N.J., Moura I.N., Roberts J.M., Hightower A.W., Bens M.S., Freeman A.R., Lee S., Stringer J.R., Duchin J.S., del Rio C., Rimland D., Baughman R.P., Levy D.A., Dietz V.J., Simon P., Navin T.R. Genetic variation in Pneumocystis carinii isolates from different geographic regions: implications for transmission. Emerg. Infect. Dis. 2000, 6:265-272.
4. Beard C.B., Fox M.R., Lawrence G.G., Guarner J., Hanzlick R.L., Huang L., del Rio C., Rimland D., Duchin J.S., Colley D.G. Genetic differences in Pneumocystis isolates recovered from immunocompetent infants and from adults with AIDS: epidemiological Implications. J. Infect. Dis. 2005, 192:1815-1818.
5. Beser J., Dini L., Botero-Kleiven S., Krabbe M., Lindh J., Hagblom P. Absence of dihydropteroate synthase gene mutations in Pneumocystis jirovecii isolated from Swedish patients. Med. Mycol. 2012, 50:320-323.
6. Calderon-Sandubete E.J., Varela-Aguilar J.M., Medrano-Ortega F.J., Nieto-Guerrer V., Respaldiza-Salas N., Horra-Padilla C., Dei-Cas E. Historical perspective on Pneumocystis carinii infection. Protist 2002, 153:303-310.
7. Choukri F., Menotti J., Sarfati C., Lucet J.C., Nevez G., Garin Y.J., Derouin F., Totet A. Quantification and spread of Pneumocystis jirovecii in the surrounding air of patients with Pneumocystis pneumonia. Clin. Infect. Dis. 2010, 51:259-265.
8. Damiani C., Choukri F., Le Gal S., Menotti J., Sarfati C., Nevez G., Derouin F., Totet A. Possible nosocomial transmission of Pneumocystis jirovecii. Emerg. Infect. Dis. 2012, 18:877-878.
9. Dumoulin A., Mazars E., Seguy N., Gargallo-Viola D., Vargas S., Cailliez J.C., Aliouat E.M., Wakefield A.E., Dei-Cas E. Transmission of Pneumocystis carinii disease from immunocompetent contacts of infected hosts to susceptible hosts. Eur. J. Clin. Microbiol. Infect. Dis. 2000, 19:671-678.
10. Esteves F., Montes-Cano M.A., de la Horra C., Costa M.C., Calderon E.J., Antunes F., Matos O. Pneumocystis jirovecii multilocus genotyping profiles in patients from Portugal and Spain. Clin. Microbiol. Infect. 2008, 14:356-362.
11. Esteves F., Gaspar J., De Sousa B., Antunes F., Mansinho K., Matos O. Clinical relevance of multiple single-nucleotide polymorphisms in Pneumocystis jirovecii Pneumonia: development of a multiplex PCR-single-base-extension methodology. J. Clin. Microbiol. 2011, 49:1810-1815.
12. Esteves F., Gaspar J., de Sousa B., Antunes F., Mansinho K., Matos O. Pneumocystis jirovecii multilocus genotyping in pooled DNA samples: a new approach for clinical and epidemiological studies. Clin. Microbiol. Infect. 2012, 18:E177-E184.
13. Friaza V., Morilla R., Respaldiza N., De La Horra C., Calderon E.J. Pneumocystis jiroveci dihydropteroate synthase gene mutations among colonized individuals and Pneumocystis pneumonia patients from Spain. Postgrad Med. 2010, 122:24-28.
14. Gigliotti F., Harmsen A.G., Wright T.W. Characterization of transmission of Pneumocystis carinii f. sp. muris through immunocompetent BALB/c mice. Infect. Immun. 2003, 71:3852-3856.
15. Gupta R., Mirdha B.R., Guleria R., Agarwal S.K., Samantaray J.C., Kumar L., Kabra S.K., Luthra K., Sreenivas V., Iyer V.K. Genotypic variation of Pneumocystis jirovecii isolates in India based on sequence diversity at mitochondrial large subunit rRNA. Int. J. Med. Microbiol. 2011, 301:267-272.
16. Hall T.A. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucl. Acids Symp. Ser. 1999, 41:95-98.
17. Hauser P.M., Francioli P., Bille J., Telenti A., Blanc D.S. Typing of Pneumocystis carinii f. sp. hominis by single-strand conformation polymorphism of four genomic regions. J. Clin. Microbiol. 1997, 35:3086-3091.
18. Hauser P.M., Blanc D.S., Sudre P., Senggen M.E., Nahimana A., Bille J., Weber R., Francioli P. Genetic diversity of Pneumocystis carinii in HIV-positive and -negative patients as revealed by PCR-SSCP typing. AIDS 2001, 15:461-466.
19. Hauser P.M., Nahimana A., Taffe P., Weber R., Francioli P., Bille J., Rabodonirina M. Interhuman transmission as a potential key parameter for geographical variation in the prevalence of Pneumocystis jirovecii dihydropteroate synthase mutations. Clin. Infect. Dis. 2010, 51:e28-33.
20. Huang L., Beard C.B., Creasman J., Levy D., Duchin J.S., Lee S., Pieniazek N., Carter J.L., del R.C., Rimland D., Navin T.R. Sulfa or sulfone prophylaxis and geographic region predict mutations in the Pneumocystis carinii dihydropteroate synthase gene. J. Infect. Dis. 2000, 182:1192-1198.
21. Huang L., Morris A., Limper A.H., Beck J.M. An official ATS workshop summary: recent advances and future directions in pneumocystis pneumonia (PCP). Proc. Am. Thorac. Soc. 2006, 3:655-664.
22. Huang L., Cattamanchi A., Davis J.L., den Boon S., Kovacs J., Meshnick S., Miller R.F., Walzer P.D., Worodria W., Masur H. International HIV-associated opportunistic pneumonias (IHOP) study; lung HIV study. HIV-associated Pneumocystis pneumonia. Proc. Am. Thorac. Soc. 2011, 8:294-300.
23. Kaneko Y., Suwa A., Ikeda Y., Hirakata M. Pneumocystis jiroveci pneumonia associated with low-dose methotrexate treatment for rheumatoid arthritis: report of two cases and review of the literature. Mod. Rheumatol. 2006, 16:36-38.
24. Kazanjian P., Armstrong W., Hossler P.A., Burman W., Richardson J., Lee C.H., Crane L., Katz J., Meshnick S.R. Pneumocystis carinii mutations are associated with duration of sulfa or sulfone prophylaxis exposure in AIDS patients. J. Infect. Dis. 2000, 182:551-557.
25. Larkin M.A., Blackshields G., Brown N.P., Chenna R., McGettigan P.A., McWilliam H., Valentin F., Wallace I.M., Wilm A., Lopez R., Thompson J.D., Gibson T.J., Higgins D.G. Clustal W and Clustal X Version 2.0. Bioinformatics 2007, 23:2947-2948.
26. Le Gal, S., Damiani, C., Perrot, M., Rouille, A., Virmaux, M., Quinio, D., Moalic, E., Saliou, P., Berthou, C., Le, M.Y., Totet, A., Nevez, G., 2012. Circulation of Pneumocystis dihydropteroate synthase mutants in France. Diagn. Microbiol. Infect. Dis. [Epub ahead of print].
27. Ma L., Borio L., Masur H., Kovacs J.A. Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use. J. Infect. Dis. 1999, 180:1969-1978.
28. Ma L., Kovacs J.A., Cargnel A., Valerio A., Fantoni G., Atzori C. Mutations in the dihydropteroate synthase gene of human-derived Pneumocystis carinii isolates from Italy are infrequent but correlate with prior sulfa prophylaxis. J. Infect. Dis. 2002, 185:1530-1532.
29. Margutti P., Visconti E., Mencarini P., Zolfo M., Marinaci S., Tamburrini E., Siracusano A., Ortona E. Typing with internal transcribed spacer regions of Pneumocystis carinii from AIDS patients with recurrent pneumonia. Res. Microbiol. 1998, 149:595-599.
30. Matos O., Esteves F. Epidemiology and clinical relevance of Pneumocystis jirovecii Frenkel, 1976 dihydropteroate synthase gene mutations. Parasite 2010, 17:219-232.
31. Medrano F.J., Montes-Cano M., Conde M., de la Horra C., Respaldiza N., Gasch A., Perez-Lozano M.J., Varela J.M., Calderon E.J. Pneumocystis jirovecii in general population. Emerg. Infect. Dis. 2005, 11:245-250.
32. Miller R.F., Ambrose H.E., Wakefield A.E. Pneumocystis carinii f. sp. hominis DNA in immunocompetent health care workers in contact with patients with P. carinii pneumonia. J. Clin. Microbiol. 2001, 39:3877-3882.
33. Miller R.F., Lindley A.R., Ambrose H.E., Malin A.S., Wakefield A.E. Genotypes of Pneumocystis jiroveci isolates obtained in Harare, Zimbabwe, and London, United Kingdom. Antimicrob. Agents Chemother. 2003, 47:3979-3981.
34. Miller R.F., Lindley A.R., Copas A., Ambrose H.E., Davies R.J., Wakefield A.E. Genotypic variation in Pneumocystis jirovecii isolates in Britain. Thorax 2005, 60:679-682.
35. Mocroft A., Ledergerber B., Katlama C., Kirk O., Reiss P., D'Arminio M.A., Knysz B., Dietrich M., Phillips A.N., Lundgren J.D. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet 2003, 362:22-29.
36. Montes-Cano M.A., de la Horra C., Martin-Juan J., Varela J.M., Torronteras R., Respaldiza N., Medrano F.J., Calderon E.J. Pneumocystis jiroveci genotypes in the Spanish population. Clin. Infect. Dis. 2004, 39:123-128.
37. Morris A., Lundgren J.D., Masur H., Walzer P.D., Hanson D.L., Frederick T., Huang L., Beard C.B., Kaplan J.E. Current epidemiology of Pneumocystis pneumonia. Emerg. Infect. Dis. 2004, 10:1713-1720.
38. Morris A., Norris K.A. Colonization by Pneumocystis jirovecii and its role in disease. Clin. Microbiol. Rev. 2012, 25:297-317.
39. Nahimana A., Blanc D.S., Francioli P., Bille J., Hauser P.M. Typing of Pneumocystis carinii f. sp. hominis by PCR-SSCP to indicate a high frequency of co-infections. J. Med. Microbiol. 2000, 49:753-758.
40. Nevez G., Jounieaux V., Linas M.D., Guyot K., Leophonte P., Massip P., Schmit J.L., Seguela J.P., Camus D., Dei-Cas E., Raccurt C., Mazars E. High frequency of Pneumocystis carinii sp. f. hominis colonization in HIV-negative patients. J. Eukaryot. Microbiol. 1997, 44:36S.
41. Nevez G., Chabé M., Rabodonirina M., Virmaux M., Dei-Cas E., Hauser P.M., Totet A. Nosocomial Pneumocystis jirovecii infections. Parasite 2008, 15:359-365.
42. Ponce C.A., Gallo M., Bustamante R., Vargas S.L. Pneumocystis colonization is highly prevalent in the autopsied lungs of the general population. Clin. Infect. Dis. 2010, 50:347-353.
43. Poppers D.M., Scherl E.J. Prophylaxis against Pneumocystis pneumonia in patients with inflammatory bowel disease: toward a standard of care. Inflamm. Bowel Dis. 2008, 14:106-113.
44. Rabodonirina M., Nahimana A., Weber R., Francioli P., Bille J., Hauser P.M. Geographical variation in the prevalence of Pneumocystis jirovecii dihydropteroate synthase mutations within Western Europe. J. Eukaryot. Microbiol. 2006, 53:112-113.
45. Riebold D., Fritzsche C., Lademann M., Bier A., Reisinger E.C. Pneumocystis jiroveci dihydropteroate synthase gene mutations at codon 171 but not at codons 55 or 57 detected in Germany. Clin. Infect. Dis. 2006, 42:582-583.
46. Robberts F.J., Liebowitz L.D., Chalkley L.J. Polymerase chain reaction detection of Pneumocystis jiroveci: evaluation of 9 assays. Diagn. Microbiol. Infect. Dis. 2007, 58:385-392.
47. Santamauro J.T., Aurora R.N., Stover D.E. Pneumocystis carinii pneumonia in patients with and without HIV infection. Compr. Ther. 2002, 28:96-108.
48. Sepkowitz K.A. Opportunistic infections in patients with and patients without acquired immunodeficiency syndrome. Clin. Infect. Dis. 2002, 34:1098-1107.
49. Tangri S., Ishioka G.Y., Huang X., Sidney J., Southwood S., Fikes J., Sette A. Structural features of peptide analogs of human histocompatibility leukocyte antigen class I epitopes that are more potent and immunogenic than wild-type peptide. J. Exp. Med. 2001, 194:833-846.
50. Valerio A., Tronconi E., Mazza F., Cargnel A., Fantoni G., Atzori C. DHPS-mutated isolates of Pneumocystis jirovecii from HIV-infected individuals: analysis of related ITS genotypes. J. Eukaryot. Microbiol. 2006, 53:108-109.
51. Valerio A., Tronconi E., Mazza F., Fantoni G., Atzori C., Tartarone F., Duca P., Cargnel A. Genotyping of Pneumocystis jiroveci pneumonia in Italian AIDS patients. Clinical outcome is influenced by dihydropteroate synthase and not by internal transcribed spacer genotype. J. Acquir. Immune Defic. Syndr. 2007, 45:521-528.
52. van Hal S.J., Gilgado F., Doyle T., Barratt J., Stark D., Meyer W., Harkness J. Clinical significance and phylogenetic relationship of novel Australian Pneumocystis jirovecii genotypes. J. Clin. Microbiol. 2009, 47:1818-1823.
53. Visconti E., Ortona E., Mencarini P., Margutti P., Marinaci S., Zolfo M., Siracusano A., Tamburrini E. Mutations in dihydropteroate synthase gene of Pneumocystis carinii in HIV patients with Pneumocystis carinii pneumonia. Int. J. Antimicrob. Agents 2001, 18:547-551.
54. Volpe G., Sbaiz L., Avanzini C., Caramello P., Savoia D. Genetic diversity of Pneumocystis carinii isolated from human immunodeficiency virus-positive patients in Turin, Italy. J. Clin. Microbiol. 2001, 39:2995-2998.
55. Wakefield A.E. DNA sequences identical to Pneumocystis carinii f. sp. carinii and Pneumocystis carinii f. sp. hominis in samples of air spora. J. Clin. Microbiol. 1996, 34:1754-1759.